Ovid Therapeutics Inc banner

Ovid Therapeutics Inc
F:1OT

Watchlist Manager
Ovid Therapeutics Inc Logo
Ovid Therapeutics Inc
F:1OT
Watchlist
Price: 1.95 EUR -3.47% Market Closed
Market Cap: €138.1m

Wall St Price Targets

1OT Price Targets Summary
Ovid Therapeutics Inc

Wall Street analysts forecast 1OT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for 1OT is 2.68 EUR with a low forecast of 1.93 EUR and a high forecast of 3.51 EUR.

Lowest Forecast
Price Target
1.93 EUR
1% Downside
Average Forecast
Price Target
2.68 EUR
38% Upside
Highest Forecast
Price Target
3.51 EUR
80% Upside
Ovid Therapeutics Inc Competitors:
Price Targets
GLAD
Gladstone Capital Corp
22% Upside
INO
Inovio Pharmaceuticals Inc
434% Upside

Revenue
Forecast

N/A
Past Growth
76% / Year
Estimated Growth
Estimates Accuracy
5%
Average Beat
N/A
Past Growth
76% / Year
Estimated Growth
Estimates Accuracy
5%
Average Beat

The compound annual growth rate for Revenue over the next 8 years is 76%.

Gross Profit
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-4%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is 1OT's stock price target?
Price Target
2.68 EUR

According to Wall Street analysts, the average 1-year price target for 1OT is 2.68 EUR with a low forecast of 1.93 EUR and a high forecast of 3.51 EUR.

What is the Revenue forecast for Ovid Therapeutics Inc?
Projected CAGR
76%

The compound annual growth rate for Revenue over the next 8 years is 76%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett